Brief: Atossa Therapeutics Provides Enrollment Update For Ongoing Phase 2 Karisma-Endoxifen Clinical Trial

Atossa Therapeutics

10/07/2023 14:23

Atossa Therapeutics Inc  ATOS.O :
    * ATOSSA THERAPEUTICS PROVIDES ENROLLMENT UPDATE FOR ONGOING
PHASE
2 KARISMA-ENDOXIFEN CLINICAL TRIAL
    * ATOSSA THERAPEUTICS - EXPECTS STUDY TO FULLY ENROLL IN Q4
OF
2023
    * ATOSSA THERAPEUTICS- 170 PATIENTS HAVE BEEN ENROLLED IN
COMPANY'S ONGOING PHASE 2 KARISMA-ENDOXIFEN CLINICAL TRIAL
    * ATOSSA THERAPEUTICS- EXPECTS STUDY TO FULLY ENROLL IN Q4
OF 2023

Source text for Eikon:  ID:nGNX8HKd57 
Further company coverage:  ATOS.O